Sign Out
Treatment and prevention of the progression of benign prostatic hyperplasia (BPH) through alleviation of symptoms, reduction of prostate size (volume), improvement of urinary flow rate and reduction of the risk of acute urinary retention (AUR) and the need for BPH-related surgery.
Avodart in combination with α-blocker tamsulosin, is indicated for the treatment of moderate to severe symptomatic BPH in men with enlarged prostate.
